Sahaj Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-04-2024
- Paid Up Capital ₹ 0.10 M
as on 25-04-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit -100.13%
(FY 2019)
- Ebitda 97.94%
(FY 2019)
- Total Assets %
(FY 2019)
About Sahaj Life Sciences India
- CIN/LLPIN
U01407TG2008PTC060210
- Company No.
060210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2008
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sahaj Life Sciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagadeesh Rangisetty  | Director | 18-Jul-2008 | Current |
| Manikreddy Pullagurla | Director | 18-Jul-2008 | Current |
Financial Performance and Corporate Structure Insights of Sahaj Life Sciences India.
Sahaj Life Sciences India Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 100.13% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sahaj Life Sciences India?
In 2017, Sahaj Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Azico Biophore India Private LimitedActive 16 years 1 monthJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Leiutis Pharmaceuticals LlpActive 3 years 7 monthsJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Biophore India Pharmaceuticals Private LimitedActive 17 years 8 monthsJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
- Zenara Pharma Private LimitedActive 20 years 9 months
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
- Alithia Pharmaceuticals Private LimitedActive 3 years 5 months
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Sionc Pharmaceuticals Private LimitedActive 16 years 10 monthsJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sahaj Life Sciences India?
Unlock and access historical data on people associated with Sahaj Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahaj Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahaj Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
